Athanasios Papatsoris

9PUBLICATIONS
24CO-AUTHORS
Pharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsHealth and ecological risk assessmentMedical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 29, 2024
Relugolix for the treatment of prostate cancer.

Panagiotis Velissarios Stamatakos, Georgios Papavasileiou, Aggeliki Leventi

|Jul 26, 2024
PSMA-based therapeutics for prostate cancer.

Panagiotis Velissarios Stamatakos, Charalampos Fragkoulis, Aggeliki Leventi

|Jun 03, 2024
Exploring pharmacological interventions in benign prostate hyperplasia: the role of cost-effectiveness analysis in daily practice and future directions.

Murtadha Almusafer, Yash Narayan, Ijeoma Nnorom

|Aug 07, 2023
An overview of hormonal directed pharmacotherapy for the treatment of prostate cancer.

Maria Mitsogianni, Athanasios Papatsoris, Vanessa-Meletia Bala

|Jun 20, 2023
Estimated Radiation Dose to the Lens During Endourologic Procedures: The Role of Leaded Glasses and the ALARA Protocol-An ESU/ESUT-YAU Endourology Group Collaboration.

Alejandra Bravo-Balado, Sofia Fontanet, Andreas Skolarikos

|Oct 11, 2022
"Glycogen deposition in the detrusor muscle of patients with bladder outlet obstruction (BOO) due to benign prostate hyperplasia (BPH); correlation with the urodynamic parameters.''.

Iraklis Mitsogiannis, Christos Komninos, Antigoni Karakosta

Pageof 2

Frequent Collaborators

1 joint publications

Mohamad Moussa

1 joint publications

Mohamed Abou Chakra

1 joint publications

Yousef Fares

1 joint publications

Athanasios Dellis